| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 2 Sep 2025 | 26 Aug 2025 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/09/2025 inter alia to consider and approve Notice is hereby given that the meeting of Board of Directors of the company will be held on Tuesday 02nd September 2025 at 3:30 P.M at 701 Arunachal Building 19 Barakhamba Road Connaught Place New Delhi-110001 interalia to transact the followingbusiness:- 1. To consider & approve the notice calling AGM of the Company for Financial Year 2024-25. 2. To consider & approve Directors Report Management Discussion and Analysis Report & Corporate Governance Report and Annexures thereto for the Financial Year 2024-25. 3. To fix the date time & venue of the AGM of the shareholders of the company for the Financial Year 2024-25. 4. To fix the dates of Book Closure & E-voting and related matters thereto. 5. To appoint Scrutinizer for the purpose of forthcoming AGM of the Company. 6. To consider and recommend the appointment of the Secretarial Auditor of the Company for a period of five consecutive financial years 7. To consider any other matter with the permission of the Board. | ||
| Board Meeting | 12 Aug 2025 | 2 Aug 2025 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Un-Audited Financial Results of the Company & Limited Review Report thereon for the quarter ended 30th June 2025 and to carry on any other business with the permission of the Board. Board of Directors of the Company in its meeting held on Tuesday, 12th August, 2025 at 3:00 P.M at the corporate office of the company situated at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded at 04:25 P.M has considered and approved the Standalone Un-audited Financial Results of the Company along with the Limited Review Report for the Standalone Un-audited Financial Results of the Company for quarter ended 30th June, 2025. (As Per BSE Announcement Dated on: 12/08/2025) | ||
| Board Meeting | 28 May 2025 | 19 May 2025 |
| Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 inter alia to consider and approve 1. To consider and approve the Audited Financial Results of the Company for the quarter and Financial Year ended 31st March 2025. 2. To consider the appointment of M/s Sanghi & Co. Chartered Accountants as the Internal Auditor of the Company for the F.Y. 2025-26. 3. To carry on any other business with the permission of the Board. Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Wednesday, 28th May, 2025 at 04:30 P.M at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded at 6 : 10 P.M has considered and approved the Standalone Audited Financial Results of the Company alongwith Auditors Report for the Standalone Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2025. (As Per BSE Announcement Dated on :28.05.2025) | ||
| Board Meeting | 13 Mar 2025 | 13 Mar 2025 |
| Outcome of independent Directors meeting held today i.e 13.03.2025 at 3:00 P.M and concluded at 3:55 P.M | ||
| Board Meeting | 12 Feb 2025 | 25 Jan 2025 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2025 inter alia to consider and approve the Un-audited Financial Results along with limited review report of the company for the quarter and nine months ended 31st December 2024. Outcome of the Board Meeting and Submission of Un-audited Financial Results for the quarter ended 31st December, 2024 as required u/r 33 of the SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on: 12/02/2025) | ||
| Board Meeting | 14 Nov 2024 | 30 Oct 2024 |
| ADVIK LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of India (LODR) Regulations 2015 notice is hereby given that as per the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations 2015 a meeting of the Board of Directors of the company is scheduled to be held on Thursday 14 th November2024 at 12:00 P.M. at the corporate office of the company at 703 Arunachal Building 19 Barakhambha Road Connaught Place New Delhi-110001 to inter-alia consider and approve the Unaudited Financial Results of the Company & Limited Review Report thereon for the quarter and half year ended 30 th September 2024 and to carry on any other business with the permission of the Board. Outcome of the Board Meeting held today i.e 14.11.2024 at 12 : 00 P.M and concluded at 1:55 P.M has already duly been uploaded withing the stipulated time period under Reg 33 of SEBI (LODR ) Regulations, 2015 (As Per BSE Announcement Dated on: 14/11/2024) | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.